Correction: LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGF R-2 signaling pathway in hepatocellular carcinoma

Fei Teng; Ju-Xiang Zhang; Qi-Meng Chang; Xu-Bo Wu; Wei-Guo Tang; Jian-Fa Wang; Jin-Feng Feng; Zi-Ping Zhang; Zhi-Qiu Hu

doi:10.1186/s13046-023-02824-9

Correction: LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGF R-2 signaling pathway in hepatocellular carcinoma

J Exp Clin Cancer Res. 2023 Sep 30;42(1):257. doi: 10.1186/s13046-023-02824-9.

Authors

Fei Teng^#^{1

2}, Ju-Xiang Zhang^#³, Qi-Meng Chang^{1

2}, Xu-Bo Wu^{1

2}, Wei-Guo Tang^{1

2}, Jian-Fa Wang^{1

2}, Jin-Feng Feng^{1

2}, Zi-Ping Zhang^{4

5}, Zhi-Qiu Hu^{6

7}

Affiliations

¹ Department of Hepatobiliary and Pancreatic Surgery, Minhang Hospital, Fudan University, Shanghai, 201199, People's Republic of China.
² 2Institute of Fudan-Minhang Academic Health System, Minhang Hospital, Fudan University, Shanghai, 201199, People's Republic of China.
³ Med-X Engineering Center for Medical Equipment and Technology, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, 200030, People's Republic of China.
⁴ Department of Hepatobiliary and Pancreatic Surgery, Minhang Hospital, Fudan University, Shanghai, 201199, People's Republic of China. zhang_zp@fudan.edu.cn.
⁵ 2Institute of Fudan-Minhang Academic Health System, Minhang Hospital, Fudan University, Shanghai, 201199, People's Republic of China. zhang_zp@fudan.edu.cn.
⁶ Department of Hepatobiliary and Pancreatic Surgery, Minhang Hospital, Fudan University, Shanghai, 201199, People's Republic of China. huzq@fudan.edu.cn.
⁷ 2Institute of Fudan-Minhang Academic Health System, Minhang Hospital, Fudan University, Shanghai, 201199, People's Republic of China. huzq@fudan.edu.cn.

^# Contributed equally.

No abstract available

Publication types

Published Erratum